Canton Barry
SEC Form 4 insider trading activity
Canton Barry has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Apr 13, 2026.
On the most recent filing, Canton Barry is listed as 10% Owner at Ginkgo Bioworks Holdings, Inc. Inside the rolling window, Canton Barry reported no open-market purchases and 3 open-market sales totaling $978K in DNA. The largest disclosed transaction in the window is a sale of 124,727 DNA shares on Apr 10, 2026, worth $802K.
Companies traded
Other insiders at DNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$978K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Canton Barry made?
Canton Barry has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Canton Barry trade?
Canton Barry has filed SEC Form 4 disclosures for 1 company, including DNA.
When was Canton Barry's most recent SEC Form 4 filing?
Canton Barry's most recent SEC Form 4 filing on Tracefour is dated Apr 13, 2026.
What is Canton Barry's total buy and sell value in the current window?
Inside the rolling retention window, Canton Barry bought $0 and sold $978K based on SEC Form 4 filings.
What was Canton Barry's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 124,727 DNA shares on 2026-04-10, worth $802K, per SEC Form 4 filings.